CTech’s Daily Israeli Tech News Roundup

Teva turns to meritocracy as part of turnaround plan. On way to crypto offering, copyright protection startup makes misleading claims. Israel could be seeing lower corporate tax rate soon

CTech 18:2118.02.18
Teva turns to meritocracy as part of turnaround plan. After canceling its annual bonuses for 2017, Teva Pharmaceutical Industries Ltd. is rolling out a new bonus plan for 2018—one that is based on both personal and company performance. Read more

 

Teva's Jerusalem fectory. Photo: Bloomberg Teva's Jerusalem fectory. Photo: Bloomberg

 

On way to crypto offering, copyright protection startup makes misleading claims. Israel-linked NKOR Ltd. is seeking to raise millions of dollars in the unregulated world of initial coin offerings. Read more

 

Israel might lower corporate tax further, says Netanyahu. Israel might consider lowering its 6% corporate tax further to compete with President Donald Trump’s tax reform, said the Israeli leader on Friday during the Munich Security Conference. Read more

 

The Israeli cannabis technology industry: 68 companies, 900 people, $76 million raised. Activity in the segment has been on the rise in Israel since 2013, according to a new report. Read more

 

Tel Aviv-based startup Perflow Medical raises $12 million. Perflow develops and manufactures devices for the treatment of neurovascular disorders including brain aneurysms. Read more

 

WeWork members to be featured in J.Crew catalog as part of a collaboration with LinkedIn and J.Crew. Eleven entrepreneurs, eight men and three women, working out of WeWork locations across the U.S., will be featured in an upcoming J.Crew catalog and sit on business panels held in collaboration with LinkedIn in J.Crew stores in San Francisco, New York, Atlanta, and Philadelphia. Read more

 

Despite hype, Chinese investors still minor players in Israel, report says. Data from past four years shows Chinese investors tend to seek out strategic tech potential rather than immediate financial performance. Read more
Cancel Send
    To all comments